Key Findings: Year-End 2024

PE: There were 86 exits totaling $6.7B in 2024.

Exits via M&A transactions accounted for the majority of exit activity (74%), while secondary buyouts contributed the largest share of exit value (71%) in the first nine months of 2024.

VC: In 2024, there were 40 exits totaling $5.2B, primarily driven by M&A.

The largest exit of 2024 was the acquisition of Hamiltonbased Fusion Pharmaceuticals, acquired by AstraZeneca for $3.3B.

PE: Privatizations in 2024 accounted for a significant portion of total dollars invested, with 14 companies going private.

2024 saw a significant surge in overall private equity investment, with $27.5B deployed across 658 deals

VC: The largest deal in 2024 was the $1.24 billion funding round raised by BC-based legaltech company Clio.

The final quarter of 2024 saw an additional $1.4B invested across 124 deals, bringing the year’s total to $7.9B invested across 592 deals

Canadian VC: Canadian Venture Capital Investments Reach $7.86 Billion Across 592 Deals in 2024